CALIFORNIA: Teva Pharmaceutical Industries Ltd has unveiled EpiPen for young children. The drug is available in most retail pharmacies at $300 for a 2-pack.
There has been a shortage of EpiPens in the United States, Europe, and Canada, mainly due to a series of manufacturing delays at Pfizer Inc’s Meridian Medical unit that produces all EpiPens sold globally at a single plant near St. Louis.
The launch of the EpiPen generic for children comes as welcome news for the company, as analysts have raised concerns over its ability to pay down its debt load, which was $28.7 billion at the end of June.
(Agencies)
Comment